Care Gaps in Sodium-Glucose Cotransporter-2 Inhibitor and Renin Angiotensin System Inhibitor Prescriptions for Patients with Diabetic Kidney Disease

被引：0
|
作者：
Sharon Rikin
Stephanie Deccy
Chenshu Zhang
Jill Crandall
Yuting Deng
Ladan Golestaneh
机构：
[1] Montefiore Medical Center and Albert Einstein College of Medicine,Division of General Internal Medicine
[2] Montefiore Medical Center and Albert Einstein College of Medicine,undefined
来源：
Journal of General Internal Medicine | 2023年 / 38卷
关键词：
chronic kidney disease; evidence-based medicine; diabetes mellitus; sodium-glucose cotransporter-2 inhibitor; renin and angiotensin system inhibitor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1599 / 1605
页数：6
相关论文
共 50 条
  • [41] Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitor use: a case report and review of the literature
    Alexis Diaz-Ramos
    Wesley Eilbert
    Diego Marquez
    International Journal of Emergency Medicine, 2019, 12
  • [42] "Normal but Catastrophic" Euglycemic Diabetic Ketoacidosis Precipitated by Sodium-Glucose Cotransporter-2 Inhibitor Use: A Case Report
    Sarno, Myrem Jesame F.
    Hernandez, Dan Philip F.
    Matulac, Melgar O.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (11)
  • [43] Euglycemic Diabetic Ketoacidosis Induced by Sodium-Glucose Cotransporter-2 Inhibitor Use and Coronary Angiography: A Case Report
    VonTungeln, Christopher D.
    Al Bataineh, Mohammad
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (01)
  • [44] Sodium-glucose cotransporter-2 inhibitor-associated erythrocytosis: A retrospective cohort study
    Liu, Jessica
    Chin-Yee, Benjamin
    Chin-Yee, Ian H.
    Ho, Jenny
    Sadikovic, Bekim
    Hsia, Cyrus C.
    JOURNAL OF INTERNAL MEDICINE, 2024, 295 (01) : 103 - 105
  • [45] A Rare Case of Sodium-Glucose Cotransporter-2 Inhibitor-Induced Acute Pancreatitis
    Haddadin, Rakahn
    Tonna, Roger F.
    Iqbal, Humzah
    Valenta, Jordan
    Iraninezhad, Homayon
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (11)
  • [46] Dapagliflozin, a selective sodium-glucose cotransporter-2 inhibitor, does not increase risk of fractures
    Johnsson, K. M.
    Ptaszynska, A.
    Mansield, T. A.
    Apanovitch, A.
    Johnsson, E.
    Parikh, S. J.
    List, J. F.
    DIABETOLOGIA, 2014, 57 : S324 - S325
  • [47] Renal Angiotensinogen and Sodium-Glucose Cotransporter-2 Inhibition: Insights from Experimental Diabetic Kidney Disease
    Burns, Kevin D.
    Cherney, David
    AMERICAN JOURNAL OF NEPHROLOGY, 2019, 49 (04) : 328 - 330
  • [48] Sodium Glucose Cotransporter-2 Inhibitor Empagliflozin Reduces Infarct Size Independently of Sodium Glucose Cotransporter-2
    Chen, Sha
    Wang, Qian
    Christodoulou, Andriana
    Mylonas, Nikolaos
    Bakker, Diane
    Nederlof, Rianne
    Hollmann, Markus W.
    Weber, Nina C.
    Coronel, Ruben
    Wakker, Vincent
    Christoffels, Vincent M.
    Andreadou, Ioanna
    Zuurbier, Coert J.
    CIRCULATION, 2023, 147 (03) : 276 - 279
  • [49] Perioperative Implication of Sodium-glucose Cotransporter-2 Inhibitor in a Patient following Major Surgery
    Vadi, Sonali
    Lad, Vidhyadhar
    Kapoor, Dheeraj
    INDIAN JOURNAL OF CRITICAL CARE MEDICINE, 2021, 25 (08) : 959 - 960
  • [50] The Kidney Protective Effects of the Sodium-Glucose Cotransporter-2 Inhibitor, Dapagliflozin, Are Present in Patients With CKD Treated With Mineralocorticoid Receptor Antagonists
    Provenzano, Michele
    Jongs, Niels
    Vart, Priya
    Stefansson, Bergur, V
    Chertow, Glenn M.
    Langkilde, Anna Maria
    McMurray, John J., V
    Correa-Rotter, Ricardo
    Rossing, Peter
    Sjostrom, C. David
    Toto, Robert D.
    Wheeler, David C.
    Heerspink, Hiddo J. L.
    KIDNEY INTERNATIONAL REPORTS, 2022, 7 (03): : 436 - 443
12345